Please login to the form below

Not currently logged in

Francois Chouinard moves from Halo Pharma to Ropack Pharma Solutions

He joins the Canadian company as a business development director

Ropack Pharma Solutions Francois ChouinardRopack Pharma Solutions has appointed Francois Chouinard as its new director of business development for research and development and formulation.

He will be responsible for the business development of the Long Island, New York drug development facilities at the contract development and manufacturing organisation (CDMO) / contract manufacturing organisation (CMO).

Chouinard brings over 20 years of experience in generic, contract development and biotech industries to the role, most recently serving as executive director of product development at Halo Pharmaceutical in Montreal, Canada.

He will report directly to Paul Dupont, vice president for marketing and business development at Canada-headquartered Ropack Pharma Solutions.

Dupont said: “Francois brings a deep understanding of the drug development process. His many years of success and experience working in the CDMO/CMO environment, are unique and valuable assets which will advance and support our mission to provide a superior customer engagement experience.”

18th February 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...